Credo Diagnostics Biomedical

🌟Now Available!✨ We’re thrilled to introduce our latest diagnostic solution, VitaSIRO 𝘴𝘰𝘭𝘰™ (https://lnkd.in/g_jRVDn8) — designed to support a wide range of users in delivering accurate and efficient results. This innovative product combines accuracy, efficiency, and ease of use to enhance your diagnostic workflow.  With its compact, streamlined design, VitaSIRO 𝘴𝘰𝘭𝘰™ seamlessly integrates into any lab setting. Combining nucleic acid extraction with real-time Polymerase Chain Reaction utilizes advanced molecular technology to deliver highly accurate results across diverse applications. Plus, its space-saving design ensures high performance without wasting valuable lab space. 👨🔬 👉 Explore how VitaSIRO 𝘴𝘰𝘭𝘰™ can elevate your laboratory diagnostics and enhance your research outcomes. Please contact us at service@credodxbiomed.com. #VitaSIROsolo #LabDiagnostics #NowAvailable #CredoDiagnostics #OfficialProductLaunch

✨Happy New Year 2025!🎉   As we step into the new year, we at Credo Diagnostics Biomedical would like to express our gratitude to our customers, partners and team members around the world. Your support and collaboration have been the driving force behind our diagnostic journey of development and excellence.   2024 has been a year of remarkable growth, and we are excited to continue our mission of driving innovation in diagnostics and making a meaningful impact on healthcare in 2025. Together, we look forward to achieving even greater milestones. 🚀 #HappyNewYear2025 #CredoDiagnostics #AdvancedMedicialTechologyforAll

🎄✨ 𝑴𝒆𝒓𝒓𝒚 𝑪𝒉𝒓𝒊𝒔𝒕𝒎𝒂𝒔 𝒂𝒏𝒅 𝑯𝒂𝒑𝒑𝒚 𝑵𝒆𝒘 𝒀𝒆𝒂𝒓!✨🎄 As the holiday season approaches, we at Credo Diagnostics Biomedical want to take a moment to express our heartfelt gratitude to our partners, customers, and colleagues worldwide. 2024 has been a remarkable year of collaboration and growth. Together, we have advanced diagnostics, strengthened partnerships, and worked towards creating a more accessible future for all.🌏🤝 💫Wishing you joy, peace, and prosperity this Christmas. May your holidays be filled with warmth, laughter, and good health. Thank you for being an important part of our journey. Let’s continue achieving new milestones together in 2025! 🎇 #MerryChristmas #SeasonGreetings #CredoDiagnostics #2024➡️ #2025

📢 Exciting Milestone for Credo Diagnostics Biomedical! Our Business Development Specialist, Benmerad Mehdi, recently visited the Virology Laboratory of the Georges Pompidou European Hospital in Paris to install the first VitaSIRO 𝘴𝘰𝘭𝘰™ instrument in Europe! 🏥 This innovative system combines advanced practicality with high efficiency. It can simultaneously detect the presence of four respiratory viruses, streamlining diagnostics for improved patient care. A big thank you to the Georges Pompidou European Hospital team for their trust and collaboration. Together, we’re driving progress in respiratory disease diagnostics! 💪   #Installation #Training #VitaSIRO𝘴𝘰𝘭𝘰 #AdvancedMedicalTechnologyforAll #CredoDiagnostics

🌍 On World AIDS Day, we join the global community in raising awareness about HIV, honoring the progress made, and recognizing the work still to be done in combating this global health challenge. At Credo Diagnostics Biomedical, we are committed to empowering healthcare professionals with advanced diagnostic tools that support early detection and timely treatment, crucial in the fight against HIV and related health challenges. 🩺💊 Together, we can drive change by promoting education, encouraging innovation, and advocating for healthcare solutions that are accessible to everyone.  Let’s unite in action and collaboration to build a healthier, more promising future for all. #WorldAIDSDay #Awareness #GlobalHealth #CredoDiagnostics #𝐓𝐚𝐤𝐞𝐭𝐡𝐞𝐑𝐢𝐠𝐡𝐭𝐬𝐏𝐚𝐭𝐡

📢 Scheduled Website Maintenance Notice 🔧 Credo Diagnostics Biomedical would like to inform you that our website will undergo scheduled maintenance from 8:00 PM on Friday, November 29 to 1:00 PM on Saturday, November 30 (GMT+8). Our website and file download services will be temporarily unavailable during this period. We sincerely apologize for any inconvenience caused and appreciate your patience as we work to enhance your experience. If you have any urgent inquiries, please contact us at service@credodxbiomed.com. Thank you for your understanding and support!

💡Did you know that a single mutation, m.1555A>G in the MT-RNR1 gene, is the primary cause of Aminoglycoside-Induced Hearing Loss (AIHL)? 👂 For patients receiving aminoglycoside antibiotics therapy, this Single Nucleotide Polymorphism (SNP) can lead to severe ototoxicity, which is particularly critical in infant care. To improve patient safety, Credo Diagnostics Biomedical has developed the 𝐌𝐓-𝐑𝐍𝐑1 𝐒𝐍𝐏 𝐀𝐬𝐬𝐚𝐲 (https://lnkd.in/gJPjThJB), a fast and accurate diagnostic solution delivering results in just 20 minutes. This rapid turnaround enables healthcare providers to make timely decisions, reducing the risk of irreversible hearing loss. 👉 Contact us at service@credodxbiomed.com to learn more about safeguarding hearing health with rapid diagnostics! #MTRNR1 #SNP #HearingLoss #CredoDiagnostics #AdvancedMedicalTechnologyforAll

🌍This week, we join the global community in observing World Antimicrobial Resistance (AMR) Awareness Week. 🦠💊 At Credo Diagnostics Biomedical, we recognize that #AMR isn’t just a medical challenge – it has far-reaching impacts on healthcare, food security, and environmental sustainability.   Antimicrobial resistance poses a significant threat to our ability to treat infections effectively. With the ongoing rise of drug-resistant pathogens, the need for accurate and timely diagnostics has never been more vital.   Credo’s solutions empower healthcare professionals with the data needed to guide treatment decisions responsibly. We are committed to raising awareness, advocating for prudent antimicrobial use, and supporting cross-sector collaborations for a healthier world.🌟   #WAAW2024 #AMR #AntimicrobialResistance #CredoDiagnostics 

🌟 New Installation Alert! 🌟   We’re excited to announce the successful installation of VitaPCR™ at Hospital CHRISTUS MUGUERZA Cumbres in Mexico! The VitaPCR™ (https://lnkd.in/g43QvWZD) will be utilized for Influenza A, Influenza B, and SARS-CoV-2 testing, providing rapid and precise diagnostics to support high-quality patient care.   What’s more, the instrument is integrated with the hospital’s LIS system using VitaDataLink™ (https://lnkd.in/ghvpBCDf), ensuring a seamless data flow and boosting operational efficiency for healthcare teams.   It’s an honor to collaborate with CHRISTUS MUGUERZA, a leading and prestigious healthcare network, to deliver advanced diagnostic solutions. Together, we’re advancing healthcare standards for communities in Mexico and beyond!   #VitaPCR #ChristusMuguerza #FluTesting #SC2Testing #ConnectedHealthcare #CredoDiagnostics #AdvancedMedicalTechnologyforAll

Credo Diagnostics Biomedical wants to take a moment to sincerely thank our distributors and partners for your ongoing support. Together, we've made a significant impact in combating infectious diseases and are preparing for the upcoming flu season. Recognizing the unique needs of each region, we are offering customized promotional packages to ensure you’re well-prepared. Based on local infection rate data, we anticipate a surge in cases and are here to help you stay ahead. If you are a healthcare provider interested in preparing for the future, please contact our local distributors or Credo directly at service@credodxbiomed.com for more information. #Healthcare #FluSeason #CredoDiagnostics #AdvancedMedicalTechnologyforAll